insights_auto
Why is 000739 down 7.69%?
Dive Deeperchevron_right
000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥21.62
arrow_downward
-7.69%(-1.80) 1D
Oct 19, 3:04:21 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CN¥23.02
High
CN¥23.57
Low
CN¥21.08
Mkt. cap
27.13B
Avg. vol.
16.57M
Volume
35.80M
Dividend
1.74%
Quarterly dividend
CN¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
29.34
52-wk high
CN¥28.50
52-wk low
CN¥14.89
EPS
CN¥0.74
Shares outstanding
1.16B
No. of employees
7K
Open
CN¥23.02
High
CN¥23.57
Low
CN¥21.08
Mkt. cap
27.13B
Avg. vol.
16.57M
Volume
35.80M
Dividend
1.74%
Quarterly dividend
CN¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
29.34
52-wk high
CN¥28.50
52-wk low
CN¥14.89
EPS
CN¥0.74
Shares outstanding
1.16B
No. of employees
7K
News stories
From web sources and news partners
qz.com
·
58 minutes ago
Eric Criscuolo on the Dow Jones climbing the wall of worry
ChartMill
·
40 minutes ago
Most Active S&P 500 Stocks on Oct. 19
The Lufkin Daily News
·
18 minutes ago
Nasdaq climbs as chip and AI-linked stocks bounce back
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd